Affordable cholesterol and glucose testing available in CSI 9KE Mini Clinic Health Stations at participating pharmacies and corporations
RENO, Nevada – February 14, 2013 – Privately owned medical kiosk manufacturer, Computerized Screening, Inc. (CSI), has rolled out its next generation 9KE enclosed telemedicine kiosk with a fully integrated Alere Cholestech LDX® Analyzer, a CLIA waived lipid testing system. In partnering with the healthcare diagnostics company, Alere Inc. (NYSE: ALR), CSI offers the only medical kiosk that measures cholesterol and glucose. In addition to screening for blood pressure, weight, blood oxygen, temperature, height and body mass index (BMI), lipid profiling rounds out a full suite of biometric screenings available in a retail, corporate, or clinic-bound health station.
“When the results of these biometric screenings are added up, they can provide a surprisingly accurate profile of risk for heart disease, stroke, high cholesterol, and diabetes – the costliest and most prevalent of all health issues” said Charles Bluth, founder and Chief Executive Officer of CSI. “When individuals know their numbers they can make lifestyle changes that help prevent future chronic illness and disability, resulting in enormous health care cost savings”.
By using the CSI 9KE Mini Clinic Health Station, Cholestech LDX® testing system, total cholesterol, HDL, LDL, triglycerides and glucose can be measured simultaneously from a single drop of blood. The easy to use, 3-step procedure uses whole blood samples from a fingerstick obtained by an on onsite administrator who has been provided with onsite training and certification. Lab-accurate results are returned within 5 minutes and populated to the patient’s Personal Health Record (PHR) created at the CSI Health station. The tests performed on the Cholestech LDX® are reimbursable by Medicare and most private payers. An on-the-spot risk assessment can also be provided by a Telemedicine video consultation with a licensed physician directly from the CSI 9KE Health Station.
About Computerized Screening, Inc. (CSI)
CSI is a privately held health care technology, medical device and information company that has been in the business of manufacturing medical kiosks in the U.S. for over 35 years. CSI’s mission has been to dramatically decrease health care costs by providing ease-of-use access to self-administered health and fitness testing, and to provide individuals with convenient access to health monitoring and assessment tools, early symptom detection, and information that promotes wellness, disease prevention, and individual responsibility for personal health. CSI technology offers innovative Telehealth solutions that enable users to establish a Personal Health Record (PHR), storage and retrieval of valuable health progress over time for personal analysis and discussion with a physician. CSI’s goal is to serve as an innovative solutions company that builds, aggregates and delivers custom programs and services through problem/solution comprehension, health care expertise, customization and open architecture. With the passage of health reform, CSI is addressing gaps in care, aiding health care cost mitigation and implementing risk improvement measures that target chronic illnesses and encourages wellness much sooner and more accurately than traditional care intervention programs.
The mission of Alere is to empower individuals to take charge of their health under the supervision of their healthcare providers and bring this vision to life by developing smart products that address broad, unmet needs and extend diagnosis from the lab, doctor’s office, and hospital to people’s homes. Alere also builds educational health management solutions around these products, which make it easier than ever to personalize care. Programs connect patients to information that yields diagnostic results, and smart platforms give healthcare providers seamless and instant access to these results, supplying them with the information they need to make the best decisions. When people are involved in their own care, they benefit from an improved quality of life, and Alere’s products and services lead to better health, less urgent medical interventions, fewer hospital visits, and reduced healthcare costs. Alere’s global leading products and services, as well as its new product development efforts, focus on cardiology, women’s health, infectious disease, oncology and toxicology. Alere is headquartered in Waltham, Massachusetts.